GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)

Brian M. Slomovitz, Wei Deng, Josh Killion, S. John Weroha, Floor Backes, David S. Miller, Meaghan Tenney, Tilley Jenkins Vogel, Lee-may Chen, Merry Jennifer Markham,

Gynecologic Oncology · 2023 · 22 citations · 0 references

DOIFull text

Open access

Concepts